Introduction
The association of coronary artery thrombosis with the onset of acute myocardial infarction has provided the rationale for the development of pharmacologic and/or physical methods for the restoration of coronary artery blood flow. The institution of pharmacologic methods for myocardial reperfusion has resulted in a reduction in mortality leading to acceptance of thrombolytic therapy as the standard approach to the management of patients with an evolving acute myocardial infarction [I] . It is a well established fact that prolonged myocardial ischemia leads to a time-dependent loss in the viability of myocardial cells in the jeopardized region of the heart and that the restoration of coronary artery blood flow is fundamental in order to arrest the progression of cell death and for the restoration of myocardial function. The restoration of blood flow is essential for repair of the reversible changes induced by ischemia and for the continued survival of the myocardial cells at risk of permanent damage. The reintroduction of oxygen at the time of reperfusion, however, may be detrimental to the reoxygenated myocyte as well as being beneficial.
A number of recent reviews have been devoted to an examination of the question of whether reactive species of oxygen or oxygen radicals can contribute to the development of irreversible myocardial cell injury during the period of reperfusion [2, 3, 4, 51 . The purpose of this editorial is to focus attention on the potential role of the polymorphonuclear leukocyte (PMN) as a determinant of the ultimate extent of irreversible myocardial injury after ischemia and reperfusion, and to call attention to those factors which modulate the inflammatory response to myocardial cell injury.
Neutrophil-dependent mediation of vessel wall and myocyte injury
The PMN possesses unique functions designed expressly for the defense of the host organism. Under certain conditions of altered physiology, the PMN may react in a manner that leads to tissue injury. The tissue damage resulting from myocardial ischemia activates a cascade of events which represents an inflammatory response that occurs independently of any improvement in myocardial reoxygenation.
The concept we wish to propose is that the inflammatory response and the invading leukocytes contribute to the ultimate extent of myocardial injury. Therefore, interventions directed against the PMN or against the cytotoxic products produced by the invading cells, should result in a reduction in the extent of tissue damage associated with myocardial ischemia and/or reperfusion. Neutrophils invade a region of ischemic myocardium long before the transmural progression of irreversible injury reaches the subepicardial myocardial region [q. Histologic studies by Sommers and Jennings [fl demonstrated that PMN were visible in the ischemic myocardium within 50 mins of reperfusion after coronary artery occlusion for 40 mins. Biochemical studies indicate that the infiltration of ischemic myocardium by PMN begins before reperfusion, and increases progressively after reperfusion. The myocardial activity of myeloperoxidase, which correlates with the histologic extent of neutrophil infiltration, exhibited a 6-fold increase after 90 mins of coronary artery occlusion without reperfusion, and a 23-fold increase after 90 mins of ischemia followed by 5 h of reperfusion [S] . PMN labeled with indium-1 11 have been employed to confirm that there is substantial accumulation of neutrophils within ischemic myocardium as early as 1 h after transient coronary artery occlusion for 40 or 90 mins [9] . Thus, reperfusion is essential in order to prevent further extension of ischemia-induced necrosis, but neutrophil-mediated injury would progress despite the restoration of blood flow to the myocardial region at risk. The factors involved in the initiation and the termination of the myocardial inflammatory response are not understood in detail, but would serve as an interesting target for the development of new therapeutic interventions aimed at preventing an extension of tissue injury either during the ischemic period or shortly after reperfusion. A number of studies (reviewed in [4] ) have demonstrated that interventions which limit neutrophil function or which interfere with the cytotoxic factors produced by the infiltrating phagocytic cells can reduce ultimate infarct size resulting from a period of regional myocardial ischemia followed by reperfusion in the experimental animal. The role of the neutrophil as a contributor to myocardial injury in response to ischemia was suggested initially in 1971 [la] . More direct studies demonstrated that ultimate infarct size was reduced by 43% in the canine heart when neutropenic as compared to control animals were subjected to 90 mins of regional myocardial ischemia followed by reperfusion for 6 h [II] ; an observation which subsequently was confirmed by other investigators using alternative means of inducing neutropenia [L?].
Additional support for the concept of neutrophil mediated myocardial injury derives from the pharmacologic modulation of neutrophil function during myocardial ischemia and reperfusion. Recognition of the mechanism of the protection afforded by ibuprofen on experimental myocardial injury was an important step in addressing the role of the neutrophil in promoting reperfusion injury. In contrast to other inhibitors of cycle-oxygenase such as indomethacin and aspirin [13, 141, ibuprofen was noted to possess myocardial protective properties without altering regional myocardial blood flow or the relationship between myocardial oxygen supply and demand [15, ISJ. An analysis of the results from the several studies mentioned, indicates that of the non-steroidal anti-inflammatory agents examined, only ibuprofen reduced neutrophil infiltration to the reperfused myocardium suggesting that the PMN contributes to the extension of the tissue injury [11, 121. Aspirin did not reduce infarct size or the in vitro neutrophil respiratory burst in response to stimulation of the PMN with C5a. This was in contrast to the response of the PMN in the presence of ibuprofen which prevented the complement induced activation of PMN and the production of oxygen radicals [14] . These studies indicate that ibuprofen, a nonsteroidal anti-inflammatory agent, does not exert its protective effect upon the myocardium by inhibition of the cycle-oxygenase pathway of arachidonic acid metabolism or by altering those factors which restore the balance between myocardial oxygen supply and demand. Further evidence for the role of the neutrophil as a mediator of reperfusion injury was derived from studies in which prostacyclin or a related analog, iloprost, as well as prostaglandin El limited ultimate infarct size in a canine model of regional ischemia and reperfusion. The mechanism of action was attributed to the ability of the prostanoids to inhibit the formation and release of neutrophil derived cytotoxic metabolites of oxygen [17, 18, 191 . The evidence derived from a number of studies is convincing and suggests that the pharmacologic inhibition of neutrophil function correlates with the observed beneficial effects on ischemic myocardial injury.
The role of the Chemotactic factors in the activation and recruitment of neutrophils One of the most important sources of inflammatory mediators involved in the acute inflammatory response is the complement system. Activation of the complement system has been shown to generate a potent neutrophi1 chemotactic factor, Csa, that plays an important role in the recruitment and activation of neutrophils, to sites of tissue injury. Proteolytic enzymes from both plasma and cell sources may also react with individual complement components resulting in the formation of inflammatory mediators, without causing generalized activation of the complement cascade. The presence of a tissue protease in ischemic myocardium was initially suggested as being involved in cleaving the third component of complement into chemotactically active fragments that may stimulate the attraction of neutrophils to the myocardium [ZO] . Recent evidence indicates that the cardiac lymphatic drainage from the ischemic myocardium contains molecules of mitochondrial and subcellular origin that are bound to C,, which may activate the complement cascade, promote the release ofleukotactic anaphylatoxins, and stimulate the migration of PMN's to sites of tissue injury [ZZ] . The central role of the complement system in the recruitment and activation of the PMN within the ischemic myocardium is illustrated by the finding that depletion of complement with cobra venom factor significantly reduced PMN infiltration into ischemic myocardium and resulted in a decrease in tissue injury associated with regional ischemia and reperfiusion [IO, 221. Complement derived products can exacerbate ischemic tissue injury and cardiac dysfunction by mechanisms which are independent of the presence of neutrophils. Neutrophil independent injury by complement may be associated with the vascular actions of the C3a, C4a, and C5a, known to enhance vascular permeability and alter vessel tone as well as through the formation of the cytolytic membrane attack complex (C5b-9) which can result in the production of transmembrane channels and facilitate the influx of extracellular calcium and disruption of myocyte function [23] .
Recent studies have also shown that endothelial cells may be an important source of a specific neutrophil chemotactic factor [24] . Treatment of endothelial cells with either interleukin-a (IL-l) or tumor necrosis factor a (TNF-a) will induce the synthesis and secretion of a neutrophil chemotactic factor similar in structure to a human monocyte derived neutrophil activating factor (NAF). NAF will not only promote neutrophil chemotaxis but also induce an increase in intracellular calcium, oxidative burst, and granule exocytosis via a GTP-binding protein dependent pathway; a response similar to that observed with other chemotactic peptides (e.g., Csa, formylmethionyl-leucyl-phenylalanine)
[25]. The potential role that endothelial cell derived mediators may play in activating neutrophils following ischemic injury has not been investigated but represents a potentially important mechanism for the activation of circulating neutrophils in ischemic myocardium.
The role of adherence-promoting cell surface glycoprotein complexes
The surface of the PMN exhibits a family of heterodimeric glycoproteins possessing a common B subunit of 95 kDa (CD18) associated noncovalently with separate ct subunits of 177, 165 and 150 kDa which are designated as LFA-1 (CD1 la), Mol or Mac-l (CD1 lb) and gp150 (CDllc) respectively. The Mol glycoprotein heterodimer is involved in the process of cellular adhesion and serves as the receptor for C3bi opsonized particles. It is believed that distinct stimuli mobilize Mol from intracellular sites and lead to its expression on the cell surface. Mol participates in adherence of the leukocyte to the endothelial cell and to other PMN's as well as in chemotaxis and spreading on cell surfaces. An increase of up to P-fold in Mol cell-surface expression has been observed therefore suggesting that at least 50% of the total population of Mol receptors is located intracellularly. The increased expression of Mol would increase neutrophil adherence to cell surfaces and facilitate chemotaxis. The increase in Mol receptor expression is coupled to the release of neutrophil gelatinase which participates in the degradation of connective tissue thereby allowing for the passage of neutrophils through capillary walls and into the extravascular space. The up-regulation of Mol, which is the receptor for CSbi, would allow for enhanced recognition and attachment to endothelial surface which have been "opsonized" (Fig. 1) Monoclonal antibodies specific for either the a or B subunits of Mol have been demonstrated to inhibit certain neutrophil/monocyte functions: (a) the binding of C3bLopsonized particles, and (b) adhesive interactions of neutrophils and monocytes including neutrophil aggregation, monocyte/neutrophil adhesion and spreading on substrates (including vascular endothelium), and chemotaxis. The leukocytes of patients who are genetically deficient in their expression of the Mol glycoprotein exhibit an impairment ofC3bi-particle binding and leukocyte adhesive interactions. It is suggested therefore that the Mol glycoprotein has a domain which functions as the plasma membrane receptor for C3bi(CR3). The critical role of Mol in the inflammatory response of activated neutrophils is suggested by the inhibitory effect of anti-MO1 monoclonal antibody on neutrophil-mediated endothelial cell injury in a rat lung model of adult respiratory distress syndrome [30] and neutrophil-dependent vascular injury in skin [.?I] . A monoclonal antibody (904) that binds to the Mol leukocyte cell adhesion-promoting glycoprotein, CD1 1 b/CD1 8, was administered to open chest anesthetized dogs 45 minutes after the induction of regional myocardial ischemia. Ischemia was produced by occluding the left circumflex coronary artery for 90 mins followed by reperfusion for 6 hours. There was no difference between control and antibody treated groups with respect to arterial blood pressure, heart rate or coronary blood flow. Administration of antibody produced no observable effect on circulating neutrophil counts, suggesting that antibodybound neutrophils were not cleared from the circulation. The mean size of myocardial infarct expressed as percentage of the area at risk of infarction that resulted was reduced by 46% with anti-MO1 treatment (Fig. 2) . The area at risk of infarction was similar between groups. Accumulation of neutrophils within the myocardium was reduced significantly with anti-MO1 antibody treatment [32] . Similar protective effects were obtained in subsequent studies with the anti-MO1 F(ab')P fragments in which antibody treatment was maintained for 48 h into the repetfusion period and infarct size determined at 72 h postreperfusion [33] . Furthermore, regional myocardial blood flow determinations indicated that both groups had equal degrees of ischemia in the inner 2/3 of the myocardium during the period of coronary artery occlusion. The results with the anti-MO1 antibody indicate that the adhesive interactions of the neutrophil may play a central role in neutrophi1 mediated damage and that inhibition of neutrophil adhesive interactions can reduce the extent of irreversible myocardial damage associated with reperfusion. The results are in accord with previously mentioned studies in which myocardial reperfusion injury was reduced by a variety of interventions which shared the one common property of altering the ability of the neutrophil to react with its target tissue: the ischemically altered myocardial cell [14, 12, IS, 191. The data from the above mentioned studies show that inhibition of neutrophil adhesion reduces the myocardial reperfusion injury and provided additional evidence for the important role of inflammatory cells in extending myocardial injury beyond that caused by the ischemic process itself. The data also support the hypothesis that a significant number of myocardial cells in the region at risk are viable after a 90-min inschemic period, but then progress to an irreversible state of injury upon reperfusion and the accumulation of polymor- platelet-activating factor, arachidonic acid metabolites and activated species of oxygen. Among the last mentioned group of neutrophi1 derived products, superoxide anion (0;)) hydrogen peroxide (HzOz), hydroxyl radical (*OH) and hypochlorous anion (OCI-) may be considered to be the most significant cytotoxic products derived from the metabolism of molecular oxygen upon perturbation of the PMN. It is proposed that the generation of the cytotoxic metabolites of oxygen generated within the micro environment formed between the adherent activated PMN's and altered endothelial cells leads to an increase in vascular permeability and myocyte damage which is "explosive" upon reperfusion as neutrophils are directed and attracted to the reperfused region under the influence of the local accumulation of chemoattractants.
During an extended period of regional ischemia of 40 mins or longer [9] , the stage is set for the neutrophil mediated inflammatory response and injury which involves cells which were normal or reversibly injured and is accelerated by reperfusion of the ischemic region. Thus, reperfusion injury involves cells which were viable or recoverable up until the time that reperfusion was instituted. It is suggested that the extension of cell death upon reperfusion of the ischemic myocardium is mediated, in part, by the neutrophil derived cytotoxic products of oxygen metabolism. It should be obvious that in the absence of reperfusion, all cells which are ischemic will undergo irreversible changes and that reperfusion is essential for survival of the myocytes which are viable up until the time of reperfusion. However, a portion of the still viable myocardial cells will undergo further injury due to the cytotoxic actions of the reactive species of oxygen.
The first suggestive evidence for the in viva participation of oxygen radicals in myocardial reperfusion injury developed from the work of Jolly et al. [35J who demonstrated that the administration of superoxide dismutase plus catalase to anesthetized dogs subjected to a 9O-min interval of regional myocardial ischemia followed by reperfusion reduced ultimate infarct size when the scavenger enzymes were administered either before the induction of regional myocardial ischemia or 1.5 mins before myocardial reperfusion. In contrast, the enzymes were without beneficial effect if they were infused 40 mins after reperfusion had been instituted. These observations suggested that an extension of myocardial injury, in addition to that associated with the ischemia-induced myocardial cell death, was occurring very early during reperfusion and that the myocardial damage could be attenuated by pretreatment with the freeradical metabolizing enzyme, superoxide dismutase. Subsequent studies have demonstrated that superoxide dismutase without the addition of catalase was equally elective in preventing the extension of myocardial injury, thereby implicating superoxide anion as the primary mediator of the myocardial damage associated with reperfusion. The relatively short pharmacologic half-life (6-10 mins) of superoxide dismutase represents a drawback to the study of the scavenger in experimental protocols which extend several days postreperfusion. Neutrophil chemoattraction to the ischemically injured myocardium and the local formation of neutrophil derived reactive species of oxygen, will continue to effect a cytotoxic influence upon the viable myocardial cells in the reperfused tissue. The free radical induced injury, therefore, occurs soon after reperfusion and is sustained, until yet to be elucidated mechanisms bring about an arrest to the damaging effects of the inflammatory response.
The inability of recent studies to demonstrate a cardioprotective effect of superoxide dismutase may be attributable to the long interval between the administration of the enzyme, which has a brief half-life (S-10 mins), and the assessment of infarct size 4 days [363 or 7 days [37J later. The validity of this concept was examined using a modified form of superoxide dismutase in which the enzyme is conjugated to polyethylene glycol (PEG-SOD) [%?I. The conjugated form of SOD has a pharmacologic half-life of 30 h. Significant plasma SOD activity can be demonstrated in the dog up to 7 days after a single intravenous administration of 1000 U/kg of PEG-SOD. Two protocols differing in the mode of administration and duration of the reperfusion interval were used. Dogs were subjected to occlusion of the circumflex coronary artery for 90 mins, then reperfused for either 6 h (Protocol A) or for 4 days (Protocol B) . The animals received either polyethylene glycol conjugated B. R. Lucched et al.
to albumin (PEG-ALB) or PEG-SOD 1000 regression line describing the relationship be-U/kg. In Protocol A, treatment was admini-tween the extent of irreversible myocardial stered starting 15 mins before coronary artery injury and collateral blood flow was shifted occulusion and continued for 2 h, terminating downward (analysis of covariance, P = 0.0 17) 15 mins after reperfusion. Infarct size was in the group of animals treated with determined 6 h later. In Protocol B, the conju-PEG-SOD. Using the mean collateral blood gated proteins were given 15 mins before flow to the inner two thirds of the ischemic reperfusion and ended simultaneously with myocardium as a covariate, infarct size exreperfusion. Infarct size was measured after 4 pressed as a percentage of the area at risk was days. A significant reduction in myocardial smaller for the PEG-SOD treated group than infarct size, expressed as a percent of the area for the PEG-ALB treated group (P < 0.05). at risk, was observed in Protocol A in the The data demonstrate that unlike unmodified group of animals which received PEG-SOD superoxide dismutase [36,37J, PEG-SOD can as compared to the PEG-ALB treated con-achieve a reduction in ultimate infarct size trols. Likewise, in the extended protocol in when quantitation of myocardial injury is which infarct size was determined 4 days after done after 4 days of reperfusion, a time when reperfusion, the PEG-SOD treated group ex-the plasma superoxide dismutase activity is hibited a significant reduction in ultimate maintained well above that found in the infarct size (Fig. 3) . Hemodynamic variables PEG-ALB control group. These data are condid not differ during the period of coronary sistent with studies noted above demonstratartery occlusion. The respective collateral ing the necessity to suppress neutrophil funcAood flows to the inner two thirds of ischemic tions up to 48 h to effect a reduction in infarct myocardium determined 60 mins after occlu-size at 72 h 1341 and support the hypothesis sion did not differ between the groups. Infarct that there exists a critical "time window" size was related inversely to collateral blood during which antineutrophil and/or antioxiflow in the PEG-ALB treated group. The dant therapy must be maintained to effect a The potential beneficial effect of PEG-SOD, as compared to the native form of the enzyme, is demonstrated in a recently published study [3!?] in which the sustained presence of the oxygen radical scavenger prevented rather than delayed the development of irreversible myocardial cell injury.
The superior efficacy of PEG-SOD compared to the native enzyme may relate to both its continued presence in the circulation and its ability to adhere to the surface of the vascular endothelium.
Polyethylene glycol conjugation of superoxide dismutase enhances cell association and uptake of the enzyme in a manner that renders the vascular endothelium more oxidant resistant. The vulnerability of the endothelium to injury from reactive species of oxygen may be related to a number of factors, which include the anatomical proximity to activated and invading inflammatory cells and localization of xanthine oxidase activity within endothelial cells. Vascular endothelial cells subjected to an ischemic equivalent of anoxic incubation followed by reoxygenation become effective generators of oxygen free radicals as determined by electron paramagnetic resonance measurements with a spin trap agent, DMPO [40] . Superoxide dismutase or catalase abolished the radical signal, suggesting that oxygen is sequentially reduced from 0; to Hz02 to *OH. Attenuation of the free radical signal by oxypurinol suggested that xanthine oxidase was a major source of the superoxide anion. It is conceivable that upon reperfusion of the ischemic myocardium, the endothelial cells as well as the adherent and infiltrating neutrophils may provide the initial source of cytotoxic species of reduced oxygen and that the subsequent inflammatory process involving the continued migration and accumulation of PMN's to the injured myocardium provides a sustained source of oxygen radicals which diminished with time as reparative processes supervene.
Regardless of the cellular site for their generation (endothelial cell, neutrophil, or other cellular loci) the role of reactive species of oxygen in mediating cellular injury associated with reperfusion has gained wide support through a number of studies which have been reviewed recently [5, 41, 4, 3] . The literature has not always agreed with the concept that reperfusion of the ischemic myocardium may result in an extension of injury beyond that which has resulted from the ischemic insult itself It is our belief that the inconsistent observations among laboratories are related to important differences in the models employed with respect to instrumentation of the heart in chronic animal studies, the duration of occlusion (90 mins vs 40 min or 3 h), and the duration therapy relative to the duration of reperfusion. Superoxide dismutase, neutrophil depletion, and ibuprofen, which inhibits neutrophil-mediated injury, did not limit the extent of myocardial injury in studies that employed a coronary occlusion lasting 3 h [4?, 43,441. Most important is the need to consider the pharmacokinetic properties of the respective interventions employed to modify the extent of reperfusion injury in view of the fact that the neutrophil mediated component of reperfusion injury may be operative for several days [34] . Previously reported negative studies with native SOD may be related to the short half-life of its free radical scavenging capacity, which compromises the chances of observing a protective effect after 4 days of reperfusion.
On the other hand, protocols which involve a 40 min ischemic interval ma) not be of sufficient duration to allow for recruitment of the inflammatory response. Thus, the resulting tissue damage may be related primarily to the ischemic insult. In the latter instance, it would be difficult to detect a beneficial response to an intervention directed against cell damage related to reperfusion which we believe is mediated in large part by the cytotoxic action of invading inflammatory cells.
The progression of tissue injury and cell death is a time dependent phenomenon involving cooperative interactions resulting in the activation of the complement system, formation of chemotactic factors, cytokine mediated stimulation of the endothelium and expression of cell surface adhesive receptors, all of which play an active role in mediating the inflammatory response. The complex sequence of events, once initiated, are likely to continue, albeit for a limited duration which may be measured in days rather than minutes. The answer to the question of whether inter-ventions administered before or at the time of reperfusion can limit the ultimate extent of tissue injury remains unanswered.
Efforts must be devoted towards eliminating differences among those studies which report disparate results. This essay has been developed with the intent of calling attention to some of the multiple factors which can mediate tissue injury. It is our hope that the reader will be stimulated toward further study, especially concerning those immunologic aspects of the problem which have as yet not been explored thoroughly in the setting of myocardial reperfusion injury. 
